£795.00

The 2023 Report on Uterine Cancer Therapeutics and Diagnostics: World Market Segmentation by City

Price data last checked 155 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 11 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 186 days • 186 data points (No recent data available)

Historical
Generating forecast...
£795.00 £755.25 £771.15 £787.05 £802.95 £818.85 £834.75 06 July 2025 21 August 2025 06 October 2025 21 November 2025 07 January 2026

Price Distribution

Price distribution over 186 days • 1 price levels

Days at Price
186 days 0 47 93 140 186 £795 Days at Price

Price Analysis

Most common price: £795 (186 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 186 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 June 2022
Listed Since
19 July 2022

Similar Products You Might Like

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States
99% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States

£520.00 21 Jan 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India
99% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India

£515.00 14 Jan 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China
98% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China

£495.00 20 Mar 2026
The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics
98% match

The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics

£795.00 26 Jan 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan
98% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan

£495.00 26 Jan 2026
The 2023 Report on Head and Neck Cancer Diagnostics: World Market Segmentation by City
98% match

The 2023 Report on Head and Neck Cancer Diagnostics: World Market Segmentation by City

£795.00 12 Jan 2026
The 2023 Report on Cervical Cancer Treatments: World Market Segmentation by City
98% match

The 2023 Report on Cervical Cancer Treatments: World Market Segmentation by City

£795.00 11 Jan 2026
The 2023 Report on Cervical Cancer Diagnostic Testing: World Market Segmentation by City
98% match

The 2023 Report on Cervical Cancer Diagnostic Testing: World Market Segmentation by City

£795.00 18 Apr 2026
The 2023 Report on Bladder Cancer Therapeutics: World Market Segmentation by City
98% match

The 2023 Report on Bladder Cancer Therapeutics: World Market Segmentation by City

£795.00 21 Apr 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 22 Jan 2026
The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City
97% match

The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City

£795.00 15 Apr 2026
The 2023 Report on Cancer Diagnostics Laboratory Tests: World Market Segmentation by City
97% match

The 2023 Report on Cancer Diagnostics Laboratory Tests: World Market Segmentation by City

£795.00 12 Jan 2026
The 2016 Report on Liver Cancer Drugs: World Market Segmentation by City
97% match

The 2016 Report on Liver Cancer Drugs: World Market Segmentation by City

£995.00 06 Jan 2026
The 2023 Report on Basal Cell Carcinoma Surgeries: World Market Segmentation by City
97% match

The 2023 Report on Basal Cell Carcinoma Surgeries: World Market Segmentation by City

£795.00 16 Dec 2025
The 2023-2028 Outlook for Cancer Screenings in the United States
97% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 15 Jan 2026
The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics
97% match

The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics

Out of Stock 22 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 10 Apr 2026
The 2023 Report on Cancer Profiling and Pathways: World Market Segmentation by City
97% match

The 2023 Report on Cancer Profiling and Pathways: World Market Segmentation by City

£795.00 12 Jan 2026
The 2023 Report on In Vitro Colorectal Cancer Testing: World Market Segmentation by City
97% match

The 2023 Report on In Vitro Colorectal Cancer Testing: World Market Segmentation by City

£795.00 19 Apr 2026
The 2023 Report on Alpha Emitters for Melanoma: World Market Segmentation by City
97% match

The 2023 Report on Alpha Emitters for Melanoma: World Market Segmentation by City

£795.00 04 Feb 2026
The 2023 Report on Chemotherapy and Antibody Combination Antibody Therapies: World Market Segmentation by City
97% match

The 2023 Report on Chemotherapy and Antibody Combination Antibody Therapies: World Market Segmentation by City

£795.00 09 Jan 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£595.00 12 Jan 2026